ClinicalTrialStartPulse: Outside the US only
6,603 clinicalTrialStartPulse: Outside the US only are listed from ClinicalTrials.gov (U.S. National Library of Medicine) API v2, dated 2026-10-21 to 2026-11-03; the most frequent is AstraZeneca with 10. Data last updated 2026-11-04; each record links to its official source and a full report.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
Includes: Sponsor, Phase, Conditions, Enrollment, Countries, Event, Posted, official source URL and score · Card, Apple Pay, Google Pay or Link via Stripe
6,603 records from ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (the 500 newest are listed here), dated 2026-10-21 to 2026-11-03. Most frequent: AstraZeneca (10). Each record links to a full report and the official source.
Last updated 2026-11-04. Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Get new ClinicalTrialStartPulse records by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
- AstraZeneca (10)
- Merck Sharp & Dohme LLC (8)
- Pfizer (8)
- Tanta University (7)
- GlaxoSmithKline (6)
How do I get new clinicalTrialStartPulse: Outside the US only by email?
Search, filter and export these records, or get alerts when new ones appear.
What are the top clinicalTrialStartPulse: Outside the US only right now?
| Record | Phase | Conditions | Enrollment |
|---|---|---|---|
| GlaxoSmithKline | Phase 3 | Ovarian Neoplasms | 720 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | Phase 3 | SCHIZOPHRENIA 1 (Disorder) | 476 |
| Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. | Phase 2 | Hyperlipoproteinemia (a) | 192 |
| Hutchmed | Phase 3 | Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation | 210 |
| InnovStone Therapeutics Limited | Phase 2 | Uncontrolled Hypertension; Resistant Hypertension | 264 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 2 | Advanced Solid Tumors | 154 |
| BeOne Medicines | Phase 2 | Hepatocellular Cancer; Liver Cancer; Hepatocellular Carcinoma | 100 |
| Genfleet Therapeutics (Shanghai) Inc. | Phase 3 | Colorectal Cancer | 368 |
| Jiangsu HengRui Medicine Co., Ltd. | Phase 3 | Diabetes Mellitus, Type 2 | 680 |
| GlaxoSmithKline | Phase 3 | Neoplasms, Endometrial | 610 |
| LuciLab | Phase 3 | Risk Behavior; Cognitive Decline | 368 |
| Innovent Biologics (Suzhou) Co. Ltd. | Phase 2 | Melanoma | 203 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | Phase 3 | Advanced or Metastatic NSCLC | 206 |
| AstraZeneca | Phase 3 | Large B-cell Lymphoma | 1200 |
| Merck Sharp & Dohme LLC | Phase 2 | Metastatic Castration-resistant Prostate Cancer | 290 |
| Keymed Biosciences Co.Ltd | 🔒 Unlock all 500 records → | ||
| Merck Sharp & Dohme LLC | 🔒 Unlock all 500 records → | ||
| Guangzhou Patronus Biotech Co., Ltd. | 🔒 Unlock all 500 records → | ||
Browse 35 more matching record reports
- Keymed Biosciences Co.Ltd
- Merck Sharp & Dohme LLC
- Guangzhou Patronus Biotech Co., Ltd.
- Merck Sharp & Dohme LLC
- DualityBio Inc.
- Qilu Pharmaceutical Co., Ltd.
- Pelage Pharmaceuticals, Inc.
- Hoffmann-La Roche
- Shanghai Mabgeek Biotech.Co.Ltd
- Kite, A Gilead Company
- Janssen Research & Development, LLC
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- AbbVie
- Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
- NS Pharma, Inc.
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- CytomX Therapeutics
- Beijing InnoCare Pharma Tech Co., Ltd.
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Biohaven Therapeutics Ltd.
- Paulex Bio Inc.
- Celltrion
- Jiangsu HengRui Medicine Co., Ltd.
- Invivyd, Inc.
- Beijing InnoCare Pharma Tech Co., Ltd.
- Tango Therapeutics, Inc.
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- CSPC Megalith Biopharmaceutical Co.,Ltd.
- AbbVie
- Grand Theravac Life Sciences (Hangzhou) Co., Ltd.
- Hoffmann-La Roche
- Jiangsu HengRui Medicine Co., Ltd.
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Jiangsu HengRui Medicine Co., Ltd.
- RemeGen Co., Ltd.
More records in this hub: page 2 · page 3 · page 4
Browse all ClinicalTrialStartPulse record reports
Which related categories and locations should I check?
Browse by phase
Not applicable (device, behavioral) (4369) Observational (2063) Phase 2 (1114) Phase 3 (576) Phase 1 (570) Phase 4 (332) Early phase 1 (91)
Browse by site location
Browse by minimum enrollment
100+ (336) 50+ (291) 300+ (99) 1,000+ (58)
Frequently asked questions
How many clinicalTrialStartPulse: Outside the US only are listed?
6,603 records from ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (the 500 newest are shown on this page), last refreshed automatically. The most recent is dated 2026-11-03.
Can I get alerts for Outside the US only?
Yes. ClinicalTrialStartPulse can email you new records matching this filter; plans are listed on the ClinicalTrialStartPulse page.
Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2. Informational only. RSS feed of new records